Levofloxacin-resistant-Streptococcus mitis endophthalmitis: a unique presentation of bacterial endocarditis.
Endogenous endophthalmitis is a rare complication of infective endocarditis and has been decreasing due to the availability of effective antibiotics. We highlight a case of endogenous endophthalmitis due to levofloxacin-resistant Streptococcus mitis presenting as infective endocarditis. Endogenous endophthalmitis should be considered as a manifestation of an underlying systemic disease, especially in patients who present with non-specific signs and symptoms with no obvious source of precipitating infection.
Dinani
Amreen
A
Department of Medicine, New York Hospital Queens, New York, USA.
Ktaich
Nessrine
N
Division of Infectious Diseases, New York Hospital Queens, New York, USA.|Department of Medicine, New York Hospital Queens, New York, USA.
Urban
Carl
C
Department of Microbiology, Weill Cornell Medical College, New York, USA.|Division of Infectious Diseases, New York Hospital Queens, New York, USA.|Department of Medicine, New York Hospital Queens, New York, USA.
Rubin
David
D
Department of Medicine, Weill Cornell Medical College, New York, USA.|Division of Infectious Diseases, New York Hospital Queens, New York, USA.|Department of Medicine, New York Hospital Queens, New York, USA.
D000368:Aged; D000369:Aged, 80 and over; D024881:Drug Resistance, Bacterial; D004452:Echocardiography; D004698:Endocarditis, Subacute Bacterial / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D009877:Endophthalmitis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D064704:Levofloxacin; D008297:Male; D015242:Ofloxacin / Q000494:pharmacology; D013290:Streptococcal Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D034361:Streptococcus mitis / Q000187:drug effects
D064704:Levofloxacin; D015242:Ofloxacin